{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:01:59Z","timestamp":1785168119375,"version":"3.55.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Genetic Engineering and Biotechnology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jgeb.2026.100670","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:27:18Z","timestamp":1775838438000},"page":"100670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational design and molecular characterization of a multi-epitope peptide vaccine targeting pancreatic cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Seyed Mostafa","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgeb.2026.100670_b0005","article-title":"Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: a model-based period analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100670_b0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"10.1016\/j.jgeb.2026.100670_b0015","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","article-title":"Burden of pancreatic cancer: from epidemiology to practice","volume":"19","author":"Khalaf","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","article-title":"Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy","volume":"12","author":"Sarantis","year":"2020","journal-title":"World J Gastrointest Oncol."},{"key":"10.1016\/j.jgeb.2026.100670_b0025","doi-asserted-by":"crossref","unstructured":"Timmer FEF, Geboers B, Nieuwenhuizen S, et al. Pancreatic cancer and immunotherapy: a clinical overview. Cancers (Basel). Aug 17 2021;13(16)doi:10.3390\/cancers13164138.","DOI":"10.3390\/cancers13164138"},{"issue":"Suppl 2","key":"10.1016\/j.jgeb.2026.100670_b0030","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr Oncol."},{"key":"10.1016\/j.jgeb.2026.100670_b0035","doi-asserted-by":"crossref","unstructured":"Ling SP, Ming LC, Dhaliwal JS, et al. Role of immunotherapy in the treatment of cancer: a systematic review. Cancers (Basel). Oct 24 2022;14(21)doi:10.3390\/cancers14215205.","DOI":"10.3390\/cancers14215205"},{"key":"10.1016\/j.jgeb.2026.100670_b0040","first-page":"3","article-title":"Cancer immunotherapies: a hope for the uncurable? Review","author":"Hamdan","year":"2023","journal-title":"Front Mol Med"},{"key":"10.1016\/j.jgeb.2026.100670_b0045","doi-asserted-by":"crossref","unstructured":"Fan T, Zhang M, Yang J, Zhu Z, Cao W, Dong C. Therapeutic cancer vaccines: advancements, challenges, and prospects. Signal Transduct Target Ther. Dec 13 2023;8(1):450. doi:10.1038\/s41392-023-01674-3.","DOI":"10.1038\/s41392-023-01674-3"},{"key":"10.1016\/j.jgeb.2026.100670_b0050","doi-asserted-by":"crossref","unstructured":"Kaczmarek M, Pozna\u0144ska J, Fechner F, et al. Cancer vaccine therapeutics: limitations and effectiveness-a literature review. Cells. Aug 28 2023;12(17)doi:10.3390\/cells12172159.","DOI":"10.3390\/cells12172159"},{"issue":"3","key":"10.1016\/j.jgeb.2026.100670_b0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.soc.2019.02.004","article-title":"Vaccine therapies for breast cancer","volume":"28","author":"Burke","year":"2019","journal-title":"Surg Oncol Clin N Am."},{"key":"10.1016\/j.jgeb.2026.100670_b0060","doi-asserted-by":"crossref","unstructured":"Peng M, Mo Y, Wang Y, et al. Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. Aug 23 2019;18(1):128. doi:10.1186\/s12943-019-1055-6.","DOI":"10.1186\/s12943-019-1055-6"},{"key":"10.1016\/j.jgeb.2026.100670_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.645641","article-title":"Expressional and prognostic value of S100A16 in pancreatic cancer via integrated bioinformatics analyses","volume":"9","author":"Tu","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10565-020-09574-w","article-title":"S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1\/2 pathways","volume":"37","author":"Fang","year":"2021","journal-title":"Cell Biol Toxicol."},{"key":"10.1016\/j.jgeb.2026.100670_b0075","doi-asserted-by":"crossref","unstructured":"Ren D, Zhao J, Sun Y, et al. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway. J Exp Clin Cancer Res. Dec 9 2019;38(1):485. doi:10.1186\/s13046-019-1496-1.","DOI":"10.1186\/s13046-019-1496-1"},{"key":"10.1016\/j.jgeb.2026.100670_b0080","doi-asserted-by":"crossref","unstructured":"Gregori A, Bergonzini C, Capula M, et al. Prognostic significance of integrin subunit alpha 2 (ITGA2) and role of mechanical cues in resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC). Cancers (Basel). Jan 19 2023;15(3)doi:10.3390\/cancers15030628.","DOI":"10.3390\/cancers15030628"},{"issue":"10","key":"10.1016\/j.jgeb.2026.100670_b0085","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1074\/mcp.M112.023507","article-title":"Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues","volume":"12","author":"Kosanam","year":"2013","journal-title":"Mol Cell Proteomics."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1078-0432.CCR-22-0794","article-title":"LAMC2 regulates key transcriptional and targetable effectors to support pancreatic cancer growth","volume":"29","author":"Erice","year":"2023","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.jgeb.2026.100670_b0095","doi-asserted-by":"crossref","unstructured":"Islam S, Kitagawa T, Baron B, Abiko Y, Chiba I, Kuramitsu Y. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Sci Rep. May 18 2021;11(1):10563. doi:10.1038\/s41598-021-90077-x.","DOI":"10.1038\/s41598-021-90077-x"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/carcin\/bgn274","article-title":"Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2","volume":"30","author":"Gordon","year":"2009","journal-title":"Carcinogenesis."},{"issue":"7","key":"10.1016\/j.jgeb.2026.100670_b0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.21037\/atm-20-2194","article-title":"Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2\/PI3K\/AKT axis","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med."},{"issue":"5","key":"10.1016\/j.jgeb.2026.100670_b0110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13031","article-title":"Zinc finger protein 91 accelerates tumour progression by activating \u03b2-catenin signalling in pancreatic cancer","volume":"54","author":"Tang","year":"2021","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2017.92","article-title":"Multi-epitope vaccines: a promising strategy against tumors and viral infections","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol Immunol."},{"key":"10.1016\/j.jgeb.2026.100670_b0120","doi-asserted-by":"crossref","unstructured":"Kar T, Narsaria U, Basak S, et al. A candidate multi-epitope vaccine against SARS-CoV-2. Sci Rep. Jul 2 2020;10(1):10895. doi:10.1038\/s41598-020-67749-1.","DOI":"10.1038\/s41598-020-67749-1"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/bib\/bbaa362","article-title":"The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies","volume":"22","author":"Waman","year":"2021","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.jgeb.2026.100670_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-801238-3.10878-5","article-title":"Bioinformatics in design of antiviral vaccines","author":"Nandy","year":"2019","journal-title":"Encyclopedia Biomed Eng"},{"key":"10.1016\/j.jgeb.2026.100670_b0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br J Cancer."},{"key":"10.1016\/j.jgeb.2026.100670_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.12","article-title":"A pipeline for computational prediction of T cell epitope candidates","volume":"114","author":"Paul","year":"2016","journal-title":"Curr Protoc Immunol."},{"issue":"10","key":"10.1016\/j.jgeb.2026.100670_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003266","article-title":"Properties of MHC class I presented peptides that enhance immunogenicity","volume":"9","author":"Calis","year":"2013","journal-title":"PLoS Comput Biol."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0155","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.humimm.2004.01.005","article-title":"Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men","volume":"65","author":"Holling","year":"2004","journal-title":"Hum Immunol."},{"key":"10.1016\/j.jgeb.2026.100670_b0160","doi-asserted-by":"crossref","unstructured":"Andreu-Sanz D, Kobold S. Role and potential of different T helper cell subsets in adoptive cell therapy. Cancers (Basel). Mar 8 2023;15(6)doi:10.3390\/cancers15061650.","DOI":"10.3390\/cancers15061650"},{"key":"10.1016\/j.jgeb.2026.100670_b0165","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3389\/fimmu.2018.01369","article-title":"Predicting HLA CD4 immunogenicity in human populations","volume":"9","author":"Dhanda","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.jgeb.2026.100670_b0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2015.03.022","article-title":"Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes","volume":"422","author":"Paul","year":"2015","journal-title":"J Immunol Methods."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100670_b0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drudis.2014.09.017","article-title":"Therapeutic applications of the cell-penetrating HIV-1 Tat peptide","volume":"20","author":"Rizzuti","year":"2015","journal-title":"Drug Discov Today."},{"key":"10.1016\/j.jgeb.2026.100670_b0180","doi-asserted-by":"crossref","unstructured":"Kim J, Yang YL, Jang SH, Jang YS. Human \u03b2-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity. Virol J. Aug 8 2018;15(1):124. doi:10.1186\/s12985-018-1035-2.","DOI":"10.1186\/s12985-018-1035-2"},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0185","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/btpr.121","article-title":"Quantitative evaluation of His-tag purification and immunoprecipitation of tristetraprolin and its mutant proteins from transfected human cells","volume":"25","author":"Cao","year":"2009","journal-title":"Biotechnol Prog. Mar-Apr"},{"key":"10.1016\/j.jgeb.2026.100670_b0190","doi-asserted-by":"crossref","unstructured":"Grote A, Hiller K, Scheer M, et al. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. Jul 1 2005;33(Web Server issue):W526-31. doi:10.1093\/nar\/gki376.","DOI":"10.1093\/nar\/gki376"},{"issue":"13","key":"10.1016\/j.jgeb.2026.100670_b0195","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jgeb.2026.100670_b0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"23","key":"10.1016\/j.jgeb.2026.100670_b0205","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics."},{"key":"10.1016\/j.jgeb.2026.100670_b0210","doi-asserted-by":"crossref","unstructured":"Saha S, Raghava GP. AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res. Jul 1 2006;34(Web Server issue):W202-9. doi:10.1093\/nar\/gkl343.","DOI":"10.1093\/nar\/gkl343"},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0215","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","article-title":"AllergenFP: allergenicity prediction by descriptor fingerprints","volume":"30","author":"Dimitrov","year":"2014","journal-title":"Bioinformatics."},{"key":"10.1016\/j.jgeb.2026.100670_b0220","series-title":"The proteomics protocols handbook","author":"Walker","year":"2005"},{"issue":"1","key":"10.1016\/j.jgeb.2026.100670_b0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","article-title":"A simple method for displaying the hydropathic character of a protein","volume":"157","author":"Kyte","year":"1982","journal-title":"J Mol Biol."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0230","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","article-title":"Calculation of protein extinction coefficients from amino acid sequence data","volume":"182","author":"Gill","year":"1989","journal-title":"Anal Biochem."},{"issue":"4773","key":"10.1016\/j.jgeb.2026.100670_b0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.3018930","article-title":"In vivo half-life of a protein is a function of its amino-terminal residue","volume":"234","author":"Bachmair","year":"1986","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.jgeb.2026.100670_b0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/protein\/4.2.155","article-title":"Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence","volume":"4","author":"Guruprasad","year":"1990","journal-title":"Protein Eng."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0245","first-page":"1895","article-title":"Thermostability and aliphatic index of globular proteins","volume":"88","author":"Ikai","year":"1980","journal-title":"J Biochem."},{"issue":"17","key":"10.1016\/j.jgeb.2026.100670_b0250","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics."},{"issue":"11","key":"10.1016\/j.jgeb.2026.100670_b0255","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/bioinformatics\/bti408","article-title":"GOR V server for protein secondary structure prediction","volume":"21","author":"Sen","year":"2005","journal-title":"Bioinformatics."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0260","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","article-title":"The PSIPRED protein structure prediction server","volume":"16","author":"McGuffin","year":"2000","journal-title":"Bioinformatics."},{"issue":"W1","key":"10.1016\/j.jgeb.2026.100670_b0265","doi-asserted-by":"crossref","first-page":"W430","DOI":"10.1093\/nar\/gkw306","article-title":"RaptorX-property: a web server for protein structure property prediction","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.jgeb.2026.100670_b0270","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nprot.2012.085","article-title":"Template-based protein structure modeling using the RaptorX web server","volume":"7","author":"K\u00e4llberg","year":"2012","journal-title":"Nat Protoc."},{"key":"10.1016\/j.jgeb.2026.100670_b0275","doi-asserted-by":"crossref","unstructured":"Heo L, Park H, Seok C. GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Res. Jul 2013;41(Web Server issue):W384-8. doi:10.1093\/nar\/gkt458.","DOI":"10.1093\/nar\/gkt458"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100670_b0280","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.jgeb.2026.100670_b0285","doi-asserted-by":"crossref","unstructured":"Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. Jul 2007;35(Web Server issue):W407-10. doi:10.1093\/nar\/gkm290.","DOI":"10.1093\/nar\/gkm290"},{"issue":"11","key":"10.1016\/j.jgeb.2026.100670_b0290","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.str.2003.10.002","article-title":"Protein disorder prediction: implications for structural proteomics","volume":"11","author":"Linding","year":"2003","journal-title":"Structure."},{"issue":"16","key":"10.1016\/j.jgeb.2026.100670_b0295","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1093\/bioinformatics\/bti541","article-title":"IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content","volume":"21","author":"Doszt\u00e1nyi","year":"2005","journal-title":"Bioinformatics."},{"key":"10.1016\/j.jgeb.2026.100670_b0300","doi-asserted-by":"crossref","unstructured":"Ponomarenko J, Bui HH, Li W, et al. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics. Dec 2 2008;9:514. doi:10.1186\/1471-2105-9-514.","DOI":"10.1186\/1471-2105-9-514"},{"key":"10.1016\/j.jgeb.2026.100670_b0305","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/1471-2105-14-346","article-title":"Disulfide by Design 2.0: a web-based tool for disulfide engineering in proteins","volume":"14","author":"Craig","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"10.1016\/j.jgeb.2026.100670_b0310","doi-asserted-by":"crossref","first-page":"W365","DOI":"10.1093\/nar\/gkx407","article-title":"HDOCK: a web server for protein-protein and protein-DNA\/RNA docking based on a hybrid strategy","volume":"45","author":"Yan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jgeb.2026.100670_b0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0320","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/prot.20151","article-title":"Predictions of protein flexibility: first-order measures","volume":"56","author":"Kovacs","year":"2004","journal-title":"Proteins."},{"key":"10.1016\/j.jgeb.2026.100670_b0325","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Blanco JR, Aliaga JI, Quintana-Ort\u00ed ES, Chac\u00f3n P. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. Jul 2014;42(Web Server issue):W271-6. doi:10.1093\/nar\/gku339.","DOI":"10.1093\/nar\/gku339"},{"issue":"20","key":"10.1016\/j.jgeb.2026.100670_b0330","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/bioinformatics\/btr497","article-title":"iMod: multipurpose normal mode analysis in internal coordinates","volume":"27","author":"Lop\u00e9z-Blanco","year":"2011","journal-title":"Bioinformatics."},{"key":"10.1016\/j.jgeb.2026.100670_b0335","doi-asserted-by":"crossref","unstructured":"Mahdevar E, Kefayat A, Safavi A, et al. Immunoprotective effect of an in silico designed multiepitope cancer vaccine with BORIS cancer-testis antigen target in a murine mammary carcinoma model. Sci Rep. Nov 30 2021;11(1):23121. doi:10.1038\/s41598-021-01770-w.","DOI":"10.1038\/s41598-021-01770-w"},{"key":"10.1016\/j.jgeb.2026.100670_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105872","article-title":"Production, purification, and in vivo evaluation of a novel multiepitope peptide vaccine consisted of immunodominant epitopes of SYCP1 and ACRBP antigens as a prophylactic melanoma vaccine","volume":"76","author":"Safavi","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100670_b0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/21645515.2020.1763693","article-title":"Efficacy of co-immunization with the DNA and peptide vaccines containing SYCP1 and ACRBP epitopes in a murine triple-negative breast cancer model","volume":"17","author":"Safavi","year":"2021","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.jgeb.2026.100670_b0350","doi-asserted-by":"crossref","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. Apr 16 2010;5(4):e9862. doi:10.1371\/journal.pone.0009862.","DOI":"10.1371\/journal.pone.0009862"},{"key":"10.1016\/j.jgeb.2026.100670_b0355","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"issue":"14","key":"10.1016\/j.jgeb.2026.100670_b0360","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1080\/07391102.2021.1883111","article-title":"Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches","volume":"40","author":"Mahdevar","year":"2022","journal-title":"J Biomol Struct Dyn."},{"key":"10.1016\/j.jgeb.2026.100670_b0365","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2019.04.030","article-title":"In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma","volume":"112","author":"Safavi","year":"2019","journal-title":"Mol Immunol."},{"issue":"48","key":"10.1016\/j.jgeb.2026.100670_b0370","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1016\/j.vaccine.2020.10.016","article-title":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","volume":"38","author":"Safavi","year":"2020","journal-title":"Vaccine."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0375","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s10989-018-9780-z","article-title":"In silico analysis of synaptonemal complex protein 1 (SYCP1) and acrosin binding protein (ACRBP) antigens to design novel multiepitope peptide cancer vaccine against breast cancer","volume":"25","author":"Safavi","year":"2019","journal-title":"Int J Peptide Res Therapeutics"},{"issue":"9","key":"10.1016\/j.jgeb.2026.100670_b0380","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"Jama."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100670_b0385","first-page":"45","article-title":"Development of a novel multi-epitope vaccine candidate against streptococcus iniae infection in fish: an immunoinformatics study","volume":"77","author":"Forouharmehr","year":"2022","journal-title":"Arch Razi Inst."},{"issue":"23","key":"10.1016\/j.jgeb.2026.100670_b0390","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100670_b0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00430-019-00640-7","article-title":"A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB\/c mice","volume":"209","author":"Vakili","year":"2020","journal-title":"Med Microbiol Immunol."},{"key":"10.1016\/j.jgeb.2026.100670_b0400","doi-asserted-by":"crossref","unstructured":"Li G, Shu J, Jin J, et al. Development of a multi-epitope vaccine for Mycoplasma hyopneumoniae and evaluation of its immune responses in mice and piglets. Int J Mol Sci. Jul 18 2022;23(14)doi:10.3390\/ijms23147899.","DOI":"10.3390\/ijms23147899"},{"issue":"19\u201320","key":"10.1016\/j.jgeb.2026.100670_b0405","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.jgeb.2026.100670_b0410","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: an in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J Theor Biol."},{"key":"10.1016\/j.jgeb.2026.100670_b0415","doi-asserted-by":"crossref","unstructured":"Kong X, Cheng D, Xu X, Zhang Y, Li X, Pan W. IFN\u2011\u03b3 induces apoptosis in gemcitabine\u2011resistant pancreatic cancer cells. Mol Med Rep. May 2024;29(5)doi:10.3892\/mmr.2024.13200.","DOI":"10.3892\/mmr.2024.13200"},{"key":"10.1016\/j.jgeb.2026.100670_b0420","article-title":"Identification and characterization of interferon-\u03b3 signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.jgeb.2026.100670_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108029","article-title":"The influence of component structural arrangement on peptide vaccine immunogenicity","volume":"60","author":"Alharbi","year":"2022","journal-title":"Biotechnol Adv."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0430","first-page":"391","article-title":"Solubility of proteins","volume":"8","author":"Vihinen","year":"2020","journal-title":"Admet Dmpk."},{"issue":"5","key":"10.1016\/j.jgeb.2026.100670_b0435","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1002\/hsr2.787","article-title":"Anaphylaxis and allergic reactions to COVID-19 vaccines: a narrative review of characteristics and potential obstacles on achieving herd immunity","volume":"5","author":"Mahdiabadi","year":"2022","journal-title":"Health Sci Rep."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0440","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jmb.2013.10.030","article-title":"Intrinsic disorder in proteins involved in the innate antiviral immunity: another flexible side of a molecular arms race","volume":"426","author":"Xue","year":"2014","journal-title":"J Mol Biol."},{"issue":"3","key":"10.1016\/j.jgeb.2026.100670_b0445","article-title":"Disordered epitopes as peptide vaccines","volume":"110","author":"MacRaild","year":"2018","journal-title":"Pept Sci (hoboken)."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0450","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600391","article-title":"From structure to redox: the diverse functional roles of disulfides and implications in disease","volume":"17","author":"Bechtel","year":"2017","journal-title":"Proteomics"},{"key":"10.1016\/j.jgeb.2026.100670_b0455","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fchem.2020.00280","article-title":"Cysteines and disulfide bonds as structure-forming units: insights from different domains of life and the potential for characterization by NMR","volume":"8","author":"Wiedemann","year":"2020","journal-title":"Front Chem."},{"key":"10.1016\/j.jgeb.2026.100670_b0460","unstructured":"Janeway CA Jr TP, Walport M, et al. . Immunobiology: The Immune System in Health and Disease. 5th edition. (The major histocompatibility complex and its functions). 2001."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0465","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.jgeb.2026.100670_b0470","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1249718","article-title":"TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview","volume":"14","author":"Kayesh","year":"2023","journal-title":"Front Microbiol."},{"issue":"4","key":"10.1016\/j.jgeb.2026.100670_b0475","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol Int."},{"issue":"9","key":"10.1016\/j.jgeb.2026.100670_b0480","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318801188","article-title":"Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer","volume":"40","author":"Lanki","year":"2018","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jgeb.2026.100670_b0485","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3145742","article-title":"Manipulation of innate and adaptive immunity through cancer vaccines","volume":"2017","author":"Sayour","year":"2017","journal-title":"J Immunol Res."},{"key":"10.1016\/j.jgeb.2026.100670_b0490","doi-asserted-by":"crossref","unstructured":"Le I, Dhandayuthapani S, Chacon J, Eiring AM, Gadad SS. Harnessing the immune system with cancer vaccines: from prevention to therapeutics. Vaccines (Basel). May 21 2022;10(5)doi:10.3390\/vaccines10050816.","DOI":"10.3390\/vaccines10050816"},{"key":"10.1016\/j.jgeb.2026.100670_b0495","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3389\/fimmu.2018.03109","article-title":"Therapeutic cancer vaccines-T cell responses and epigenetic modulation","volume":"9","author":"Kartikasari","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.jgeb.2026.100670_b0500","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000496166","article-title":"B cell-based cancer immunotherapy","volume":"46","author":"Wennhold","year":"2019","journal-title":"Transfus Med Hemother."},{"key":"10.1016\/j.jgeb.2026.100670_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1582305","article-title":"Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets","volume":"16","author":"Pan","year":"2025","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.jgeb.2026.100670_b0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008607","article-title":"In silico veritas? potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction","volume":"16","author":"Silva-Arrieta","year":"2020","journal-title":"PLoS Pathog."}],"container-title":["Journal of Genetic Engineering and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687157X26000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:45:27Z","timestamp":1785167127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687157X26000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1687157X26000144"],"URL":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100670","relation":{},"ISSN":["1687-157X"],"issn-type":[{"value":"1687-157X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational design and molecular characterization of a multi-epitope peptide vaccine targeting pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Genetic Engineering and Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgeb.2026.100670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Academy of Scientific Research and Technology.","name":"copyright","label":"Copyright"}],"article-number":"100670"}}